NLRP3-induced systemic inflammation controls the development of JAK2V617F mutant myeloproliferative neoplasms.
Nature communications
View this publicationNature communications
View this publicationEuropean journal of haematology
View this publicationHIV medicine
View this publicationHematology (Amsterdam, Netherlands)
View this publicationFrontiers in immunology
View this publicationFrontiers in immunology
View this publicationFrontiers in oncology
View this publicationNature medicine
View this publicationJournal for immunotherapy of cancer
View this publicationJournal of cancer research and clinical oncology
View this publication